These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


673 related items for PubMed ID: 18687557

  • 1. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
    Huang L, Sun L, Xu G, Xia T.
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
    [Abstract] [Full Text] [Related]

  • 2. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
    Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ, Tsakris A.
    J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
    [Abstract] [Full Text] [Related]

  • 3. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [Abstract] [Full Text] [Related]

  • 4. Role of OXA-23 and AdeABC efflux pump for acquiring carbapenem resistance in an Acinetobacter baumannii strain carrying the blaOXA-66 gene.
    Lee Y, Yum JH, Kim CK, Yong D, Jeon EH, Jeong SH, Ahn JY, Lee K.
    Ann Clin Lab Sci; 2010 Sep; 40(1):43-8. PubMed ID: 20124329
    [Abstract] [Full Text] [Related]

  • 5. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
    Lin L, Ling BD, Li XZ.
    Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612
    [Abstract] [Full Text] [Related]

  • 6. [Role of the AdeABC efflux pump in carbapenems resistance of clinical isolates of Acinetobacter baumannii].
    Ma Z, Cai SX, Tong WC, Ruan SC, Wang H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1378-81. PubMed ID: 21868328
    [Abstract] [Full Text] [Related]

  • 7. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
    Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P.
    J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718
    [Abstract] [Full Text] [Related]

  • 8. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
    Stoeva T, Higgins PG, Bojkova K, Seifert H.
    Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK, Jung SI, Park KH, Kim SH, Ko KS.
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [Abstract] [Full Text] [Related]

  • 10. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
    Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, Heo ST, Kim SW, Chang HH, Cheong HS, Chung DR, Peck KR, Song JH, Ko KS.
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
    [Abstract] [Full Text] [Related]

  • 11. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E, Chmielarczyk A, Heczko P, Seifert H, Higgins PG.
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [Abstract] [Full Text] [Related]

  • 12. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE, Luiz SO, Scheffer MC, Gales AC, Paganini MC, Nascimento AJ, Carignano E, Dalla Costa LM.
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.
    Chen Y, Ai L, Guo P, Huang H, Wu Z, Liang X, Liao K.
    BMC Infect Dis; 2018 Dec 04; 18(1):614. PubMed ID: 30509192
    [Abstract] [Full Text] [Related]

  • 14. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
    Poirel L, Lebessi E, Héritier C, Patsoura A, Foustoukou M, Nordmann P.
    Clin Microbiol Infect; 2006 Nov 04; 12(11):1138-41. PubMed ID: 17002616
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, Soroush S, Mohammadi-Yegane S.
    Jpn J Infect Dis; 2008 Jul 04; 61(4):274-8. PubMed ID: 18653968
    [Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
    Zarrilli R, Casillo R, Di Popolo A, Tripodi MF, Bagattini M, Cuccurullo S, Crivaro V, Ragone E, Mattei A, Galdieri N, Triassi M, Utili R.
    Clin Microbiol Infect; 2007 May 04; 13(5):481-9. PubMed ID: 17430339
    [Abstract] [Full Text] [Related]

  • 17. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM, Towner KJ, Marchel H, Luczak M.
    Clin Microbiol Infect; 2007 May 04; 13(5):490-6. PubMed ID: 17331123
    [Abstract] [Full Text] [Related]

  • 18. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.
    J Hosp Infect; 2009 Jul 04; 72(3):234-42. PubMed ID: 19493588
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii.
    Fernández Cuenca F, Sánchez Mdel C, Caballero-Moyano FJ, Vila J, Martínez-Martínez L, Bou G, Baño JR, Pascual A.
    Int J Antimicrob Agents; 2012 Jun 04; 39(6):472-7. PubMed ID: 22445494
    [Abstract] [Full Text] [Related]

  • 20. Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum beta-lactamase in an intensive care unit.
    Jeong SH, Bae IK, Kwon SB, Lee K, Yong D, Woo GJ, Lee JH, Jung HI, Jang SJ, Sung KH, Lee SH.
    J Hosp Infect; 2005 Mar 04; 59(3):242-8. PubMed ID: 15694982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.